News

Hieff™ Low dsRNA T7 RNA Polymerase Mutants, Empowering mRNA Vaccine and Therapy Development

Hieff™ Low dsRNA T7 RNA Polymerase Mutants, Empowering mRNA Vaccine and Therapy Development

Breakthrough Achievement from Yeasen  and Molefuture biotechnology With the rapid development of biotechnology, mRNA therapy, as an emerging treatm...
Hieff™ Low dsRNA T7 RNA Polymerase Mutants, Empowering mRNA Vaccine and Therapy Development

Hieff™ Low dsRNA T7 RNA Polymerase Mutants, Empowering mRNA Vaccine and Therapy Development

Breakthrough Achievement from Yeasen  and Molefuture biotechnology With the rapid development of biotechnology, mRNA therapy, as an emerging treatm...
Special offer up to 70% off

Special offer up to 70% off

As a supplier of life science reagents, we are delighted to share some exciting news for the upcoming month from Sep to Nov. We are extending a spe...
Distributors wanted

Distributors wanted

Distributors wanted Dear potential partners around the world:We are Yeasen Biotechnology, a company that specializes inproviding raw materials for ...

Inquiry